Xilong Scientific (002584.SZ) released its 2024 half-year performance forecast. The net income attributable to shareholders of listed companies during the reporting period is expected to be between 32 million yuan and 45 million yuan, a year-on-year increase of 154.93%-258.49%. After deducting non-recurring gains and losses, the net income is expected to be between 30 million yuan and 40 million yuan, a year-on-year increase of 378.43%-537.91%. The basic earnings per share are expected to be between 0.05 yuan/share and 0.08 yuan/share.

The net income attributable to shareholders of listed companies in the first half of 2024 increased compared with the same period last year. The main reason is that the market demand for chemical reagents and special chemicals increased during the reporting period, and both revenue and profit increased year-on-year. In addition, the company continues to improve its management level, and takes multiple measures to achieve year-on-year growth in the first half of the year, further enhancing profitability and market competitiveness.